These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 19830593)

  • 41. An exploration of differences between Japan and two European countries in the self-reporting and valuation of pain and discomfort on the EQ-5D.
    Feng Y; Herdman M; van Nooten F; Cleeland C; Parkin D; Ikeda S; Igarashi A; Devlin NJ
    Qual Life Res; 2017 Aug; 26(8):2067-2078. PubMed ID: 28343350
    [TBL] [Abstract][Full Text] [Related]  

  • 42. EQ-5D-3L health status and health state utilities of the oldest-old (85 +) in Germany: results from the AgeCoDe-AgeQualiDe study.
    König HH; Brettschneider C; Lühmann D; Kaduszkiewicz H; Oey A; Wiese B; Werle J; Weyerer S; Fuchs A; Pentzek M; Conrad I; Röhr S; Weeg D; Bickel H; Heser K; Wagner M; Scherer M; Maier W; Riedel-Heller SG; Hajek A
    Qual Life Res; 2020 Dec; 29(12):3223-3232. PubMed ID: 32851600
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Mapping the SF-12 to preference-based instruments: convergent validity in a low-income, minority population.
    Franks P; Lubetkin EI; Gold MR; Tancredi DJ
    Med Care; 2003 Nov; 41(11):1277-83. PubMed ID: 14583690
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Construct validity for the Health Utilities Index in a sleep center.
    Welch KC; Scharf SM
    Sleep Breath; 2007 Dec; 11(4):295-303. PubMed ID: 17457630
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Interchangeability of the EQ-5D and the SF-6D, and comparison of their psychometric properties in a spinal postoperative Spanish population.
    Selva-Sevilla C; Ferrara P; Gerónimo-Pardo M
    Eur J Health Econ; 2020 Jun; 21(4):649-662. PubMed ID: 32065301
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Assessing the health of the general population in England: how do the three- and five-level versions of EQ-5D compare?
    Feng Y; Devlin N; Herdman M
    Health Qual Life Outcomes; 2015 Oct; 13():171. PubMed ID: 26489956
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A comparison of the health utilities indices Mark 2 and Mark 3 in type 2 diabetes.
    Maddigan SL; Feeny DH; Johnson JA;
    Med Decis Making; 2003; 23(6):489-501. PubMed ID: 14672109
    [TBL] [Abstract][Full Text] [Related]  

  • 48. EQ-5D health utilities: exploring ways to improve upon responsiveness in psoriasis.
    Pickard AS; Gooderham M; Hartz S; Nicolay C
    J Med Econ; 2017 Jan; 20(1):19-27. PubMed ID: 27471948
    [TBL] [Abstract][Full Text] [Related]  

  • 49. US and UK versions of the EQ-5D preference weights: does choice of preference weights make a difference?
    Huang IC; Willke RJ; Atkinson MJ; Lenderking WR; Frangakis C; Wu AW
    Qual Life Res; 2007 Aug; 16(6):1065-72. PubMed ID: 17415683
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Multivariable Regression Model of the EuroQol 5-Dimension Questionnaire in Patients Seeking Outpatient Low Vision Rehabilitation.
    Malkin AG; Goldstein JE; Massof RW
    Ophthalmic Epidemiol; 2017 Jun; 24(3):174-180. PubMed ID: 28045563
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Health-related quality of life measured using the EQ-5D-5L: South Australian population norms.
    McCaffrey N; Kaambwa B; Currow DC; Ratcliffe J
    Health Qual Life Outcomes; 2016 Sep; 14(1):133. PubMed ID: 27644755
    [TBL] [Abstract][Full Text] [Related]  

  • 52. EQ-5D self-reported health in Barbados and Jamaica with EQ-5D-5L population norms for the English-speaking Caribbean.
    Bailey H; Janssen MF; La Foucade A; Boodraj G; Wharton M; Castillo P
    Health Qual Life Outcomes; 2021 Mar; 19(1):97. PubMed ID: 33741000
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Discriminative validity of the EQ-5D-5 L and SF-12 in older adults with arthritis.
    Tawiah AK; Al Sayah F; Ohinmaa A; Johnson JA
    Health Qual Life Outcomes; 2019 Apr; 17(1):68. PubMed ID: 30995930
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Comparison of the EQ-5D and SF-12 health surveys in a general population survey in Alberta, Canada.
    Johnson JA; Pickard AS
    Med Care; 2000 Jan; 38(1):115-21. PubMed ID: 10630726
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The responsiveness of EQ-5D utility scores in patients with depression: A comparison with instruments measuring quality of life, psychopathology and social functioning.
    Günther OH; Roick C; Angermeyer MC; König HH
    J Affect Disord; 2008 Jan; 105(1-3):81-91. PubMed ID: 17532051
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Cross-sectional validation of the PROMIS-Preference scoring system.
    Hanmer J; Dewitt B; Yu L; Tsevat J; Roberts M; Revicki D; Pilkonis PA; Hess R; Hays RD; Fischhoff B; Feeny D; Condon D; Cella D
    PLoS One; 2018; 13(7):e0201093. PubMed ID: 30063733
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The EQ-5D and the Health Utilities Index for permanent sequelae after meningitis: a head-to-head comparison.
    Oostenbrink R; A Moll HA; Essink-Bot ML
    J Clin Epidemiol; 2002 Aug; 55(8):791-9. PubMed ID: 12384194
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Mapping analysis to predict EQ-5D-5 L utility values based on the Oxford Hip Score (OHS) and Oxford Knee Score (OKS) questionnaires in the Spanish population suffering from lower limb osteoarthritis.
    Martín-Fernández J; Morey-Montalvo M; Tomás-García N; Martín-Ramos E; Muñoz-García JC; Polentinos-Castro E; Rodríguez-Martínez G; Arenaza JC; García-Pérez L; Magdalena-Armas L; Bilbao A
    Health Qual Life Outcomes; 2020 Jun; 18(1):184. PubMed ID: 32539838
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Mapping MOS-HIV to HUI3 and EQ-5D-3L in Patients With HIV.
    Joyce VR; Sun H; Barnett PG; Bansback N; Griffin SC; Bayoumi AM; Anis AH; Sculpher M; Cameron W; Brown ST; Holodniy M; Owens DK
    MDM Policy Pract; 2017; 2(2):2381468317716440. PubMed ID: 30288427
    [No Abstract]   [Full Text] [Related]  

  • 60. Preference-based SF-6D scores derived from the SF-36 and SF-12 have different discriminative power in a population health survey.
    Luo N; Wang P; Fu AZ; Johnson JA; Coons SJ
    Med Care; 2012 Jul; 50(7):627-32. PubMed ID: 22456112
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.